Factors involved in continuance of atazanavir-based regimens: Results from a cohort of HIV1-positive patients
文摘
m" id="list_ulist0010">

The switch from ATV/r to unboosted ATV doubles the time of ATV administration.

Different toxicity and discontinuation rates have emerged in women and in subjects who switched from ATV/r to unboosted ATV.

Therapeutic failure has been significantly related to CD4<200/μL at ATV start and detectable HIV-RNA after 6 months of ATV.

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.